Prognostic factors for SARS-CoV-2 nasopharyngeal swab negativity: a multicentric study

Submitted: 21 November 2022
Accepted: 31 December 2022
Published: 31 December 2022
Abstract Views: 865
PDF: 148
HTML: 11
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


The diagnosis of coronavirus disease 2019 (COVID-19) is made by the detection of viral RNA by polymerase chain reaction on nasopharyngeal swabs. In some patients the test is falsely negative, while other biological samples are positive. The aim of the study is to identify characteristics and prognostic factors for swab negativity in COVID-19 patients with deep aspirate bronchus (BA)-confirmed disease. Multicentric retrospective case-control study of patients admitted for COVID-19 between March and November 2020 in two internal medicine units of the AOU Careggi and in the Internal Medicine of the Hospital of Varese. Were enrolled patients aged ≥18 years hospitalized for COVID-19 with viral RNA isolation on biological specimen, considering as cases the patients negative to swab but positive to BA. For each case, four controls with positive swab at admission were enrolled. The study included 95 patients, 19 cases and 76 controls. The mean time between symptoms onset and swab was 2.65±1.9 days in cases, with a statistically significant (P=0.003) difference compared to controls (5.53±3.0 days). Patients with negative swab had a longer mean length of stay and more frequent adverse outcome than controls. Swabbing within a short time of symptoms onset is a predictor for false negative. Patients with repeated negative swabs have a worse clinical picture with longer hospital stay, greater need for non-invasive ventilation and higher frequency of adverse outcome.



PlumX Metrics


Download data is not yet available.


Para O, Caruso L, Pestelli G, et al. Ferritin as prognostic marker in COVID-19: the FerVid study. Postgrad Med 2022;134:58-63.
FIND, the global alliance for diagnostics. COVID-19 diagnostics and testing. Available from:
Li L, Liang Y, Hu F, et al. Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients. Virology 2020;551:26-35.
Tan GC, Cheong SK. Challenges of Covid-19 testing. Malays J Pathol 2020;42:1.
Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA 2020 [Epub ahead of print].
Kucirka LM, Lauer SA, Laeyendecker O, et al. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann Intern Med 2020;18;173:262-7.
Winichakoon P, Chaiwarith R, Liwsrisakun C, et al. Negative nasopharyngeal and oropharyngeal swabs do not rule out COVID-19. J Clin Microbiol 2020;23;58:e00297-20.
Bentivegna M, Hulme C, Ebell MH. Primary care relevant risk factors for adverse outcomes in patients with COVID-19 infection: a systematic review. J Am Board Fam Med 2021;34:S113-26.
Petito E, Falcinelli E, Paliani U, et al; COVID study investigators. Neutrophil more than platelet activation associates with thrombotic complications in COVID-19 patients. J Infect Dis 2020;6:756.
Kwee RM, Adams HJA, Kwee TC. Diagnostic performance of CO-RADS and the RSNA classification system in evaluating COVID-19 at chest CT: a meta-analysis. Radiol Cardiothorac Imaging 2021;14;3:e2005-10.
Ramachandran P, Perisetti A, Gajendran M, et al. Pre-hospitalization proton pump inhibitor use and clinical outcomes in COVID-19. Eur J Gastroenterol Hepatol 2020 [Epub ahead of print].
Hariyanto TI, Prasetya IB, Kurniawan A. Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection. Dig Liver Dis 2020;52:1410-2.

How to Cite

Para, O., Caruso, L., Pestelli, C., Pestelli, G., Fedi, G., Guidi, S., Abenante, A., & Nozzoli, C. (2022). Prognostic factors for SARS-CoV-2 nasopharyngeal swab negativity: a multicentric study. Italian Journal of Medicine, 16(1).

Similar Articles

You may also start an advanced similarity search for this article.